Supporting adherence to antiretroviral therapy with mobile phone reminders: Results from a cohort in South India

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Rodrigues, Rashmi ^a,b   Shet, Anita ^a,b   Antony, Jimmy ^b   Sidney, Kristi ^a   Arumugam, Karthika ^b   Krishnamurthy, Shubha ^b   D'Souza, George ^b   DeCosta, Ayesha ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INTERACTIVE VOICE RESPONSE SYSTEM; MAJOR CLINICAL STUDY; MALE; MOBILE PHONE; PATIENT COMPLIANCE; QUASI EXPERIMENTAL STUDY; REMINDER SYSTEM; TEXT MESSAGING;

ADULT; ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; CELLULAR PHONE; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INDIA; MALE; MEDICATION ADHERENCE; PATIENT COMPLIANCE; REMINDER SYSTEMS; TEXT MESSAGING;

EID: 84865420620     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040723     Document Type: Article

References (51)

1. Bhat VG, Ramburuth M, Singh M, Titi O, Antony AP, et al. (2010) Factors associated with poor adherence to anti-retroviral therapy in patients attending a rural health centre in South Africa. Eur J Clin Microbiol Infect Dis 29: 947-953.
2. Roberts KJ, (2000) Barriers to and facilitators of HIV-positive patients' adherence to antiretroviral treatment regimens. AIDS Patient Care STDS 14: 155-168.
3. Bartlett JA, (2002) Addressing the challenges of adherence. J Acquir Immune Defic Syndr 29 Suppl 1: S2-10.
4. Ickovics JR, Meisler AW, (1997) Adherence in AIDS clinical trials: a framework for clinical research and clinical care. J Clin Epidemiol 50: 385-391.
5. Read T, Mijch A, Fairley CK, (2003) Adherence to antiretroviral therapy: are we doing enough? Intern Med J 33: 254-256.
6. Altice FL, Springer SA, (2010) DAART for human immunodeficiency virus-infected patients: Studying subjects not at risk for nonadherence and use of untested interventions. Arch Intern Med 170: 109-110.
7. Nyanzi-Wakholi B, Lara AM, Munderi P, Gilks C, (2011) The charms and challenges of antiretroviral therapy in Uganda: the DART experience. AIDS Care 24: 137-142.
8. Rigsby MO, Rosen MI, Beauvais JE, Cramer JA, Rainey PM, et al. (2000) Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention. J Gen Intern Med 15: 841-847.
9. Tesoriero J, French T, Weiss L, Waters M, Finkelstein R, et al. (2003) Stability of adherence to highly active antiretroviral therapy over time among clients enrolled in the treatment adherence demonstration project. J Acquir Immune Defic Syndr 33: 484-493.
10. Boyer EW, Smelson D, Fletcher R, Ziedonis D, Picard RW, (2010) Wireless Technologies, Ubiquitous Computing and Mobile Health: Application to Drug Abuse Treatment and Compliance with HIV Therapies. J Med Toxicol 6: 212-216.
11. Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, et al. (2010) Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet 376: 1838-1845.
12. Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, et al. (2011) Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS 25: 825-834.
13. Kalichman SC, Kalichman MO, Cherry C, Swetzes C, Amaral CM, et al. (2011) Brief behavioral self-regulation counseling for HIV treatment adherence delivered by cell phone: an initial test of concept trial. AIDS Patient Care STDS 25: 303-310.
14. Vital Wave Consulting (2009) mHealth for development: The opportunity of mobile technology for healthcare in the developing world.
15. Armstrong AW, Watson AJ, Makredes M, Frangos JE, Kimball AB, et al. (2009) Text-message reminders to improve sunscreen use: a randomized, controlled trial using electronic monitoring. Arch Dermatol 145: 1230-1236.
16. Crankshaw T, Corless IB, Giddy J, Nicholas PK, Eichbaum Q, (2010) Exploring the patterns of use and the feasibility of using cellular phones for clinic appointment reminders and adherence messages in an antiretroviral treatment clinic, Durban, South Africa. AIDS patient care and STDs 24: 729-734.
17. Hardy H, Kumar V, Doros G, Farmer E, Drainoni ML, et al. (2011) Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy. AIDS Patient Care STDS 25: 153-161.
18. TRAI (2011) The Indian telecom services performance Indicators January- March 2011. Mahanagar Doorsanchar Bhawan JLNM, New Delhi, India: Telecom Regulatory Authority of India.
19. NACO (2011) National AIDS Control Organisation Annual Report 2010-11. India: Ministry of Health and Family Welfare.
20. Freedberg KA, Kumarasamy N, Losina E, Cecelia AJ, Scott CA, et al. (2007) Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy. Aids 21 Suppl 4: S117-128.
21. NACO (2007) Antiretroviral therapy guidelines for HIV-infected adults and adolescents including post-exposure prophylaxis. Government of India: Ministry of Health and Family Welfare.
22. NIAID Adult AIDS Clinical Trials Group (2003) Adherence barriers self report (ql0777).
23. Kunutsor S, Walley J, Katabira E, Muchuro S, Balidawa H, et al. (2010) Clinic attendance for medication refills and medication adherence amongst an antiretroviral treatment cohort in Uganda: A prospective study. AIDS Research and Treatment.
24. Simoni JM, Amico KR, Pearson CR, Malow R, (2008) Strategies for promoting adherence to antiretroviral therapy: a review of the literature. Curr Infect Dis Rep 10: 515-521.
25. Cote JK, Godin G, (2005) Efficacy of interventions in improving adherence to antiretroviral therapy. Int J STD AIDS 16: 335-343.
26. Puccio JA, Belzer M, Olson J, Martinez M, Salata C, et al. (2006) The use of cell phone reminder calls for assisting HIV-infected adolescents and young adults to adhere to highly active antiretroviral therapy: a pilot study. AIDS Patient Care STDS 20: 438-444.
27. Uzma Q, Emmanuel F, Ather U, Zaman S, (2011) Efficacy of Interventions for Improving Antiretroviral Therapy Adherence in HIV/AIDS Cases at PIMS, Islamabad. J Int Assoc Physicians AIDS Care (Chic) 10: 373-383.
28. Cauldbeck MB, O'Connor C, O'Connor MB, Saunders JA, Rao B, et al. (2009) Adherence to anti-retroviral therapy among HIV patients in Bangalore, India. AIDS Research and Therapy.
29. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, et al. (2000) Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 12: 255-266.
30. El-Khatib Z, Ekstrom AM, Coovadia A, Abrams EJ, Petzold M, et al. (2011) Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa- a prospective cohort study. BMC Public Health 11: 88.
31. Woods SP, Moran LM, Carey CL, Dawson MS, Iudicello JE, et al. (2008) Prospective memory in HIV infection: is "remembering to remember" a unique predictor of self-reported medication management? Arch Clin Neuropsychol 23: 257-270.
32. Safren SA, Hendriksen ES, Desousa N, Boswell SL, Mayer KH, (2003) Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care 15: 787-793.
33. Lyon ME, Trexler C, Akpan-Townsend C, Pao M, Selden K, et al. (2003) A family group approach to increasing adherence to therapy in HIV-infected youths: results of a pilot project. AIDS Patient Care STDS 17: 299-308.
34. Roux P, Kouanfack C, Cohen J, Marcellin F, Boyer S, et al. (2011) Adherence to antiretroviral treatment in HIV-positive patients in the Cameroon context: promoting the use of medication reminder methods. J Acquir Immune Defic Syndr 57 Suppl 1: S40-43.
35. Person AK, Blain ML, Jiang H, Rasmussen PW, Stout JE, (2011) Text messaging for enhancement of testing and treatment for tuberculosis, human immunodeficiency virus, and syphilis: a survey of attitudes toward cellular phones and healthcare. Telemed J E Health 17: 189-195.
36. Chung MH, Richardson BA, Tapia K, Benki-Nugent S, Kiarie JN, et al. (2011) A randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomes. PLoS Med 8: e1000422.
37. Shet A, Arumugam K, Rodrigues R, Rajagopalan N, Shubha K, et al. (2010) Designing a mobile phone-based intervention to promote adherence to antiretroviral therapy in South India. AIDS Behav 14: 716-720.
38. Sidney K, Antony J, Rodrigues R, Arumugam K, Krishnamurthy S, et al. (2011) Supporting patient adherence to antiretrovirals using mobile phone reminders patient responses from South India. AIDS Care 24: 612-617.
39. Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lester RT, Mills E, et al. (2011) The Cameroon mobile phone SMS (CAMPS) trial: a protocol for a randomized controlled trial of mobile phone text messaging versus usual care for improving adherence to highly active anti-retroviral therapy. Trials 12: 5.
40. De Costa A, Shet A, Kumarasamy N, Ashorn P, Eriksson B, et al. (2010) Design of a randomized trial to evaluate the influence of mobile phone reminders on adherence to first line antiretroviral treatment in South India-the HIVIND study protocol. BMC Med Res Methodol 10: 25.
41. Rudd P, Byyny RL, Zachary V, LoVerde ME, Titus C, et al. (1989) The natural history of medication compliance in a drug trial: limitations of pill counts. Clin Pharmacol Ther 46: 169-176.
42. Reidel K, Tamblyn R, Patel V, Huang A, (2008) Pilot study of an interactive voice response system to improve medication refill compliance. BMC Med Inform Decis Mak 8: 46.
43. Milam J, Richardson JL, McCutchan A, Stoyanoff S, Weiss J, et al. (2005) Effect of a brief antiretroviral adherence intervention delivered by HIV care providers. J Acquir Immune Defic Syndr 40: 356-363.
44. Kaplan WA, (2006) Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries? Global Health 2: 9.
45. Kunutsor S, Walley J, Katabira E, Muchuro S, Balidawa H, et al. (2010) Using mobile phones to improve clinic attendance amongst an antiretroviral treatment cohort in rural Uganda: a cross-sectional and prospective study. AIDS Research and Treatment.
46. Nachega JB, Chaisson RE, Goliath R, Efron A, Chaudhary MA, et al. (2011) Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy. Aids 24: 1273-1280.
47. Granger BB, Bosworth HB, (2011) Medication adherence: emerging use of technology. Curr Opin Cardiol 26: 279-287.
48. Reynolds NR, Testa MA, Su M, Chesney MA, Neidig JL, et al. (2008) Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial. J Acquir Immune Defic Syndr 47: 62-68.
49. Bastard M, Fall MB, Laniece I, Taverne B, Desclaux A, et al. (2011) Revisiting long-term adherence to highly active antiretroviral therapy in Senegal using latent class analysis. J Acquir Immune Defic Syndr 57: 55-61.
50. Harris AD, Bradham DD, Baumgarten M, Zuckerman IH, Fink JC, et al. (2004) The use and interpretation of quasi-experimental studies in infectious diseases. Clin Infect Dis 38: 1586-1591.
51. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, et al. (2009) Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. Bmj 338: b2393.